Medical Research
(H300)
IRS Verified
DX Registered
990 on File
AMERICAN ASSOCIATION FOR CANCER RESEARCH
Financial strength (30%)
83/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$129.5M
Total Revenue
$97.7M
Total Expenses
$264.1M
Net Assets
295
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
87.2%
Fundraising Efficiency
N/A
Operating Reserve
32.45x
Liability-to-Asset
21.7%
Revenue Diversification
50.1%
Executive Compensation
$2.9M
Compared with Peers
FY 2025
Compared with 46 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
87.2% | 81.5% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
11.7% | 11.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
1.1% | 0.2% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
32.5 mo | 18.6 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
21.7% | 22.3% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
50.1% | 84.5% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-5.8% | 7.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
11.0% | 5.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
24.6% | 2.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $129.5M | $97.7M | $264.1M | 87.2% | 295 |
| 2024 | $137.4M | $88.0M | $220.2M | 86.8% | 301 |
| 2023 | $74.3M | $80.2M | $170.5M | 87.4% | 277 |
| 2022 | $83.1M | $83.0M | $152.3M | 89.2% | 280 |
| 2021 | $103.2M | $68.3M | N/A | — | 235 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.